Physician profile
Dean A Klug
NPI 1265548713
$37,398.21
in general payments reported to CMS, 2019-2025
24 companies · $22K in 2025
The $22K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $380 · 2021: $529 · 2022: $3,086 · 2023: $9,815 · 2024: $1,137 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Food and Beverage: $4,817 · Travel and Lodging: $2,643 · Education: $54.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,939.00 |
| Food and Beverage | $4,817.00 |
| Travel and Lodging | $2,643.35 |
| Education | $54.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $28,153.65 | 2019-2025 | Dupixent |
| Aerin Medical INC. | $2,336.74 | 2023-2025 | |
| Genzyme Corporation | $1,756.56 | 2019-2025 | |
| Acclarent, INC | $1,663.60 | 2019-2024 | Relieva Spinplus, Relieva Ultirra, Trudi Nav Cable |
| Medical Device Business Services, INC. | $945.76 | 2022 | |
| Integra Lifesciences Corporation | $721.83 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Intersect Ent, INC. | $454.71 | 2019-2021 | |
| Glaxosmithkline, LLC. | $365.53 | 2022-2025 | Nucala |
| Neurent Medical Limited | $173.90 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Abbvie INC. | $167.16 | 2023 | |
| Medtronic USA, INC. | $138.50 | 2019 | |
| Medtronic, INC. | $111.28 | 2022 | |
| Optinose US, INC. | $74.86 | 2019-2024 | |
| Stryker Corporation | $57.70 | 2019 | |
| Sanofi-Aventis U.S. LLC | $54.95 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $43.36 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $35.18 | 2025 | Tezspire |
| Smith+Nephew, INC. | $29.13 | 2019 | |
| Allergan, INC. | $27.27 | 2022 | |
| Hologic Sales and Service, LLC | $24.54 | 2023 | Coolseal Generator |
| Baxter Healthcare | $23.36 | 2023 | Floseal |
| Hikma Pharmaceuticals USA | $14.66 | 2024 | Ryaltris |
| Merck Sharp & Dohme LLC | $12.83 | 2023 | |
| Genentech USA, INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Klug listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.